Philip N. Patsalos

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Drug-drug interactions between antiseizure medications and antipsychotic medications: a narrative review and expert opinion.

Drug-drug interactions between antiseizure medications and antipsychotic medications: a narrative review and expert opinion.

Journal: Expert opinion on drug metabolism & toxicology

Published: November 05, 2023

Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force.

Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force.

Journal: Epilepsia open

Published: October 29, 2021

Pharmacokinetic characterization of favipiravir in patients with COVID-19.

Pharmacokinetic characterization of favipiravir in patients with COVID-19.

Journal: British journal of clinical pharmacology

Published: June 15, 2021

Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.

Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.

Journal: Epilepsia

Published: May 05, 2020

Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects.

Therapeutic drug monitoring of antiepileptic drugs: current status and future prospects.

Journal: Expert opinion on drug metabolism & toxicology

Published: February 15, 2020

Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study.

Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study.

Journal: BMC neurology

Published: June 26, 2019

Volumetric Absorptive Microsampling: A New Sampling Tool for Therapeutic Drug Monitoring of Antiepileptic Drugs.

Volumetric Absorptive Microsampling: A New Sampling Tool for Therapeutic Drug Monitoring of Antiepileptic Drugs.

Journal: Therapeutic drug monitoring

Published: May 17, 2019

Corrigendum to "The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy" [Epilepsy Res. 148 (2018) 17-22].

Corrigendum to "The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy" [Epilepsy Res. 148 (2018) 17-22].

Journal: Epilepsy research

Published: January 02, 2019

Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update.

Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update.

Journal: Therapeutic drug monitoring

Published: June 30, 2018

The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy.

The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy.

Journal: Epilepsy research

Published: June 21, 2018

Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: A comparison of free non-protein-bound concentrations.

Serum protein binding of 25 antiepileptic drugs in a routine clinical setting: A comparison of free non-protein-bound concentrations.

Journal: Epilepsia

Published: April 21, 2017

Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.

Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.

Journal: Seizure

Published: January 17, 2017

Showing 1-12 of 25

Last Updated: 09/26/2026